71 West Capital Partners’s Health Catalyst HCAT Stock Holding History

71 West Capital Partners’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$676K	Hold	339,515	–	–	0.02%	183
2026 Q1	$431K	Buy	339,515 +179,466	+112%	+$338K	0.02%	185
2025 Q4	$383K	Buy	+160,049	New	+$438K	0.02%	167

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

71 West Capital Partners's HCAT Position: Q2 2026 in Review

71 West Capital Partners held its Health Catalyst (HCAT) position steady in Q2 2026 at 339,515 shares worth $676K. The position accounts for 0.02% of the portfolio, ranked #183.

71 West Capital Partners first reported a position in HCAT in Q4 2025 and has held it in 3 quarters since. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

71 West Capital Partners held 339,515 shares of Health Catalyst worth $676K as of Q2 2026.
71 West Capital Partners left its Health Catalyst share count unchanged in Q2 2026.
Health Catalyst made up 0.02% of 71 West Capital Partners's portfolio in Q2 2026, its #183 holding.
71 West Capital Partners first reported a position in Health Catalyst in Q4 2025 and has held it in 3 quarters since.
126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on 71 West Capital Partners's 13F filing for Q2 2026, filed 4 Aug 2026.